Stay updated on Pembrolizumab in EOC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in EOC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in EOC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Page revision updated to v3.6.3, indicating a small update to the page's underlying template/assets; no study content changes are reflected in this update.
    Difference
    0.1%
    Check dated 2026-07-03T23:23:55.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page's revision label at the bottom was updated from Revision: v3.6.0 to Revision: v3.6.2, signaling a minor metadata update to the study record page.
    Difference
    0.1%
    Check dated 2026-06-26T23:19:17.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The study page now indicates the trial is no longer recruiting. New navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading formatting was updated with a new page revision noted as v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T14:11:15.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.5.5, indicating a small internal update to the page's documentation or rendering.
    Difference
    0.1%
    Check dated 2026-06-05T10:26:28.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Added a new page revision label 'Revision: v3.5.4' and removed the previous 'Revision: v3.5.3', indicating an update to the page metadata. The update appears to reflect record maintenance rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-05-15T05:35:33.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The page’s software/version label was updated from Revision v3.5.2 to v3.5.3, indicating a minor site release without altering the clinical trial study details.
    Difference
    0.1%
    Check dated 2026-04-24T06:25:34.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in EOC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in EOC Clinical Trial page.